XTLBNasdaqPharmaceutical Preparations
XTL BIOPHARMACEUTICALS LTD
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Jun 30, 2026
$1.96−0.00 (-0.01%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Price history
Daily open, high, low, close and volume
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected. | ||||||
Stock splits
From SEC filings
| Date | Ratio | Effect on per-share figures |
|---|---|---|
| Mar 25, 2026 | 1-for-4 reverse | Earlier per-share figures multiplied by 4 |
| Feb 10, 2017 | 1-for-5 reverse | Earlier per-share figures multiplied by 5 |
| Oct 4, 2012 | 1-for-10 reverse | Earlier per-share figures multiplied by 10 |